IOMED is a leader in the development, manufacturing and marketing of non-invasive, active drug delivery systems in the physical and occupational therapy and sports medicine markets. We have the largest patent portfolio covering iontophoresis technology in the industry, as well as established brand recognition with our products. Since introducing the first commercial active drug delivery product in 1979, our products have been clinically administered in over 14 million patient treatments for the delivery of medications, with over 12 million of those treatments having occurred since 1990.

2005 Shareholder Letter  |  2006 Shareholder Letter